Peter A. Todd
Impact in
- Pharmaceutical Science top 1%
- Pharmacology top 1%
- Antibiotics Pharmacokinetics and Efficacy
- Pharmacogenetics and Drug Metabolism
- Inflammatory mediators and NSAID effects
Papers in
- Pharmacology 15
- Inflammatory mediators and NSAID effects 8
- Antibiotics Pharmacokinetics and Efficacy 7
-
- Blood Pressure and Hypertension Studies 7
- Renin-Angiotensin System Studies 6
- Cardiac electrophysiology and arrhythmias 2
- Heart Failure Treatment and Management 2
- Co-authors
- Eugene M. Sorkin (2 shared papers)Paul Benfield (5 shared papers)Karen L. Goa (7 shared papers)Rex N. Brogden (6 shared papers)Stephen P. Clissold (3 shared papers)Deborah M. Campoli-Richards (3 shared papers)Rennie C. Heel (2 shared papers)Allan H. Price (1 shared paper)
- Journals
- Drugs (36 papers)
- Partner nations
- United KingdomBelgium
In The Last Decade
Peter A. Todd
36 papers receiving 3.4k citations
Peter A. Todd's Hit Papers
Peers
Comparison fields: 5 of 133
- Pharmaceutical Science 270
- Pharmacology 544
- Cardiology and Cardiovascular Medicine 704
- Molecular Medicine 173
- Applied Microbiology and Biotechnology 60
Countries citing papers authored by Peter A. Todd
This map shows the geographic impact of Peter A. Todd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter A. Todd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter A. Todd more than expected).
Fields of papers citing papers by Peter A. Todd
This network shows the impact of papers produced by Peter A. Todd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter A. Todd. The network helps show where Peter A. Todd may publish in the future.
Co-authors
The 19 scholars most cited alongside Peter A. Todd, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Ciprofloxacin Hit paper breakdown → | 1988 | 662 |
| 2 | Diclofenac Sodium Hit paper breakdown → | 1988 | 461 |
| 3 | 1988 | 268 | |
| 4 | 1986 | 233 | |
| 5 | 1990 | 188 | |
| 6 | 1990 | 180 | |
| 7 | 1990 | 161 | |
| 8 | 1988 | 141 | |
| 9 | 1989 | 132 | |
| 10 | 1987 | 114 | |
| 11 | 1988 | 114 | |
| 12 | 1987 | 105 | |
| 13 | 1989 | 100 | |
| 14 | 1987 | 84 | |
| 15 | 1991 | 84 | |
| 16 | 1991 | 80 | |
| 17 | 1990 | 72 | |
| 18 | 1992 | 71 | |
| 19 | 1989 | 69 | |
| 20 | 1992 | 67 |
About Peter A. Todd
Peter A. Todd is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine, Molecular Medicine, Surgery and Transplantation, having authored 36 papers that have together received 3.9k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (8 papers), Blood Pressure and Hypertension Studies (7 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers), Renin-Angiotensin System Studies (6 papers), Lipoproteins and Cardiovascular Health (4 papers), Antibiotic Resistance in Bacteria (3 papers), Cardiac electrophysiology and arrhythmias (2 papers) and Heart Failure Treatment and Management (2 papers). The work is most often cited by research in Pharmaceutical Science (270 citations), Pharmacology (544 citations), Cardiology and Cardiovascular Medicine (704 citations), Molecular Medicine (173 citations) and Applied Microbiology and Biotechnology (60 citations). Peter A. Todd has collaborated with scholars based in United Kingdom and Belgium. Frequent co-authors include Eugene M. Sorkin, Paul Benfield, Karen L. Goa, Rex N. Brogden, Stephen P. Clissold, Deborah M. Campoli-Richards, Rennie C. Heel, Allan H. Price, Alan Ward and Diana M. Faulds. Their work appears in journals such as Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.